News

Subjective memory complaints predict clinical impairment


 

AT CTAD

The risk of an observed impairment was significantly reduced by the use of antihypertensives (HR, 0.34) and a report of high cholesterol (HR, 0.75).

Dr. Abner acknowledged certain limitations of the study, including the fact that most clinical impairments are not yet confirmed by medical review. In addition, "relevant early to midlife socioeconomic status exposures were not measured, which may mitigate the effect observed for black race," she said. "Also, many of our black participants were recruited from Veterans Affairs sites, so their exposures may be qualitatively different in terms of their risk of head trauma and PTSD [posttraumatic stress disorder]. Overall, the sample was highly educated and healthy."

Screening of the full PREADVISE cohort is expected to be completed in early 2014.

The study is funded by the National Institute on Aging. Dr. Abner said she had no relevant financial conflicts to disclose.

dbrunk@frontlinemedcom.com

Pages

Recommended Reading

Amyloid imaging scans limited to specific patients in clinical trials
MDedge Family Medicine
Extended delirium raises cognitive risk in critically ill
MDedge Family Medicine
Breast cancer hormone therapy may affect cognitive function
MDedge Family Medicine
FDA okays flutemetamol for color-enhanced amyloid imaging
MDedge Family Medicine
Johnson & Johnson agrees to pay billions in drug misbranding settlement
MDedge Family Medicine
Don’t ignore headaches in teens with bipolar disorder
MDedge Family Medicine
Small study: TBI leads to rapid deposition of brain amyloid
MDedge Family Medicine
Memantine helped to delay driving impairment in early Alzheimer’s
MDedge Family Medicine
Good news: ‘fibrofog’ doesn’t portend Alzheimer’s
MDedge Family Medicine
Cholinesterase inhibitors most effective in mild Alzheimer’s
MDedge Family Medicine